在全膝关节整形手术后,GLP-1激动剂有保护作用
Rachel Ranson1, Philip M Parel1, Julia Kirkland2
1Department of Orthopaedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC, United States.
在全膝关节整形手术 (TKA) 之前使用葡萄糖类-1受体激活剂 (GLP1RAs) 减少了早期医学并发症,但增加了急性功能衰竭的风险. 长期的手术结果没有受到GLP1RA的影响.
科学领域:
- 骨科手术
- 内分泌学
- 药理学
背景情况:
- 葡萄糖类-1受体激活剂 (GLP1RAs) 是已知的2型糖尿病和肥胖症的治疗方法.
- GLP1RA对全膝关节整形术 (TKA) 后的结果的影响尚不清楚.
研究的目的:
- 评估GLP1RA使用对TKA后90天的医学并发症的影响.
- 评估GLP1RA对TKA患者2年手术结果的影响.
主要方法:
- 全国所有付款人索赔数据库的回顾性队列分析.
- 主要TKA患者分为GLP1RA使用者 (在手术前6个月内) 和非使用者.
- 使用回归分析对90天的再入院,医疗并发症和2年的手术并发症进行比较.
主要成果:
- 使用GLP1RA与较低的90天再入院率 (OR:0. 77) 和较少的并发症,如心律失常,死亡和深静脉血栓形成有关.
- 在GLP1RA组中观察到急性功能衰竭的风险增加 (OR: 1. 16).
- 两组之间没有发现两年手术结果的显著差异.
结论:
- GLP1RA的使用与TKA后早期医学并发症的减少有关,这可能是由于体重减轻和血糖控制的好处.
- 在TKA后,GLP1RA与急性功能衰竭的风险增加有关.
- GLP1RAs似乎没有影响TKA后的长期外科治疗结果,其益处仅限于早期的术后期.
更多相关视频
03:53Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
Published on: March 15, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Peripheral Artery Disease V: Postoperative Nursing Management
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Glinides
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
